Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Hypertension Reviews
  4. Volume 21, Issue 1
  5. Article
Volume 21, Issue 1
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Introduction

Hypertension is a worldwide problem that affects people of all ethnicities and social groups. Its mortality rate has been steadily increasing. However, several pharmacological compounds have been used to manage hypertension and related issues. Calcium Channel Blockers (CCBs) based on Dihydropyridine (DHP) are used as first-line therapy. It is well established that simple adjustments to an existing medicine's fundamental structure can considerably improve its efficacy.

Materials and Methods

The purpose of this research study was to create potential antihypertensive drugs utilizing a 1,4-DHP scaffold and analyze their binding processes with different calcium channel proteins for comparative analysis, with PDB IDs 3LV3, 1T0J, and 6DAF. This study used molecular docking and ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling to predict the binding efficacy of newly produced potential drugs, such as CCBs.

Results

The binding energy of the protein with the newly created compounds ranged between -2.6 and -7.26 kcal/mol (3LV3), -7.42 to -10.36 kcal/mol (1T0J), and -6.63 to -11.98 kcal/mol (6DAF).

Discussion

The predicted ADMET profiling yielded significant results, indicating that among the virtually prepared ligands, apart from the standard drugs amlodipine and nifedipine, ligand numbers and showed a favorable ADMET profile.

Conclusion

In this study, drug development efforts focused on modifying existing hypertension medications through analysis. From hundreds of synthesized ligands, 19 showed optimal docking scores. ADMET profiling of these 19 ligands revealed ligands 60 and 13 to have favorable profiles. The Swiss ADME and ADMET lab 2.0 tools confirmed these findings, highlighting their potential for further development.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021328359241206073629
2024-12-16
2025-05-12

  • From This Site

    /content/journals/chyr/10.2174/0115734021328359241206073629
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WilliamsB. ManciaG. SpieringW. Agabiti RoseiE. AziziM. BurnierM. ClementD.L. CocaA. De SimoneG. DominiczakA. KahanT. 2018 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH).Eur. Heart J.201839333021310410.1093/eurheartj/ehy33930165516
     [Google Scholar]
  2. WrightJM MusiniVM GillR First-line drugs for hypertension.Cochrane Database Syst. Rev.201844CD00184110.1002/14651858.CD001841.pub3
     [Google Scholar]
  3. McKeeverR.G. HamiltonR.J. Calcium Channel Blockers.StatpearlStatpearl publishers2022
     [Google Scholar]
  4. GodfraindT. Calcium channel blockers in cardiovascular pharmacotherapy.J. Cardiovasc. Pharmacol. Ther.201419650151510.1177/107424841453050824872348
     [Google Scholar]
  5. JamalianA. MiriR. FiruziO. AminiM. Moosavi-MovahediA.A. ShafieeaA. Synthesis, cytotoxicity and calcium antagonist activity of novel imidazolyl derivatives of 1,8-acridinediones.J. Indian Chem. Soc.201184983991
     [Google Scholar]
  6. WangA.L. IadecolaC. WangG. New generations of dihydropyridines for treatment of hypertension.J. Geriatr. Cardiol.2017141677210.11909/j.issn.1671‑5411.2017.01.00628270844
     [Google Scholar]
  7. CoburnR.A. WierzbaM. SutoM.J. SoloA.J. TriggleA.M. TriggleD.J. 1,4-Dihydropyridine antagonist activities at the calcium channel: A quantitative structure-activity relationship approach.J. Med. Chem.198831112103210710.1021/jm00119a0092846838
     [Google Scholar]
  8. RameshM. MatoweW.C. WolowykM.W. KnausE.E. Synthesis and calcium channel antagonist activity of alkyl t-butyl esters of nifedipine analogues containing pyridinyl substituents.Drug Des. Deliv.19872279892855571
     [Google Scholar]
  9. FleckensteinA. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.Annu. Rev. Pharmacol. Toxicol.197717114916610.1146/annurev.pa.17.040177.001053326161
     [Google Scholar]
  10. RovnyakG. AndersenN. GougoutasJ. HedbergA. KimballS.D. MalleyM. MorelandS. PorubcanM. PudzianowskiA. Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.J. Med. Chem.198831593694410.1021/jm00400a0082834556
     [Google Scholar]
  11. NavidpourL. MiriR. ShafieeA. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.Arzneimittelforschung200454949950415500195
     [Google Scholar]
  12. DavoodA. MansouriN. DehpourA.R. ShafaroudiH. AlipourE. ShafieeA. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.ChemInform20063739chin.20063915810.1002/chin.200639158
     [Google Scholar]
  13. HemmateenejadB. MiriR. EdrakiN. KhoshneviszadehM. ShafieeA. Molecular modeling and QSAR analysis of some 4,5-dichloroimidazolyl-1,4-DHP-based calcium channel blockers.J. Indian Chem. Soc.200742182193
     [Google Scholar]
  14. KitchenD.B. DecornezH. FurrJ.R. BajorathJ. Docking and scoring in virtual screening for drug discovery: Methods and applications.Nat. Rev. Drug Discov.200431193594910.1038/nrd154915520816
     [Google Scholar]
  15. DainaA. MichielinO. ZoeteV. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Sci. Rep.2017714271710.1038/srep4271728256516
     [Google Scholar]
  16. KaurA. KaurJ. BansalR. Microwave mediated synthesis & analytical method development for the estimation of novel 1, 4-dihydropyridines in bulk by RP-HPLC.Drug Res. (Stuttg.)201868529630010.1055/s‑0043‑12066329100264
     [Google Scholar]
/content/journals/chyr/10.2174/0115734021328359241206073629
Loading
Discovery of New Symmetrical and Asymmetrical 1,4-dihydropyridine Derivatives as Potential Antihypertensive Agents: An In silico Evaluation
Current Hypertension Reviews 21, 45 (2025); https://doi.org/10.2174/0115734021328359241206073629
/content/journals/chyr/10.2174/0115734021328359241206073629
/content/journals/chyr/10.2174/0115734021328359241206073629
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): 1,4-dihydropyridines; ADMET profile; angiotensin receptor blockers; antihypertensive; calcium channel blockers; Hypertension

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test